Mesothelin as a biomarker for targeted therapy | Biomarker Research | Full Text

Mesothelin as a biomarker for targeted therapy | Biomarker Research | Full Text

Mesothelin as a biomarker for targeted therapy

CAR-T cell therapy targeting CD19 has achieved remarkable success in the treatment of B cell malignancies, while various solid malignancies are still refractory for lack of suitable target. In recent years, a ...

Authors:Jiang Lv and Peng Li

Citation:Biomarker Research 2019 7:18

Content type:Review

Published on: 23 August 2019

• ViewFull Text
 
• ViewPDF